文献速递心境障碍

重性抑郁障碍及其症状亚型的蛋白质组学特征

Proteomic Signatures in Major Depressive Disorder and Depression Symptom Subtypes.
PubMed 文献 · Am J Psychiatry · 2026-09-30

该研究基于荷兰抑郁与焦虑研究队列1881名参与者,使用SomaScan平台检测7289种血浆分析物,比较当前重性抑郁障碍、缓解期重性抑郁障碍与健康对照,并分析抑郁症状严重度及忧郁型与非典型症状维度与蛋白质的关联。结果显示当前重性抑郁障碍与健康对照间有7种独特蛋白质差异显著,总体症状严重度关联18种蛋白质,非典型症状关联57种独特蛋白质,而忧郁型症状无个体蛋白质达到FDR显著。通路分析提示细胞外基质组织、补体级联等通路富集,支持重性抑郁障碍的生物学异质性,症状维度比分类诊断有更强的外周蛋白质组关联。

要点

  • 当前重性抑郁障碍与健康对照间有7种独特血浆蛋白质差异显著。
  • 非典型症状关联57种独特蛋白质,总体症状严重度关联18种。
  • 忧郁型症状无个体蛋白质达到FDR显著,但存在通路水平富集。

核心结论

  • 重性抑郁障碍存在生物学异质性,外周蛋白质组改变在特定症状维度上比分类诊断更为明显。
  • 非典型症状表现出显著的个体蛋白质关联及通路水平富集,支持采用维度框架改善抑郁症的生物学分层。

研究设计与样本

  • 研究使用SomaScan平台对荷兰抑郁与焦虑研究中1881名参与者的血浆7289种分析物进行蛋白质组学分析。
  • 参与者包括当前重性抑郁障碍469例、缓解期重性抑郁障碍918例和健康对照494例。
  • 分析评估了诊断状态、症状严重度以及DSM-IV定义的忧郁型和非典型症状维度与蛋白质的关联,并进行通路富集分析。

主要发现

  • 当前重性抑郁障碍与健康对照组之间,经FDR校正后有8个适配体(代表7种独特蛋白质)差异显著。
  • 总体抑郁症状严重度与18个显著适配体相关,对应18种独特蛋白质。
  • 非典型症状与58个显著适配体相关,对应57种独特蛋白质。
  • 忧郁型症状没有个体蛋白质达到FDR显著性。
  • 通路分析显示总体症状严重度富集于细胞外基质组织、胶原形成、补体级联信号、血小板激活和止血等通路。

关键数值与推荐

  • 当前重性抑郁障碍与健康对照比较,FDR校正后8个适配体(7种独特蛋白质)差异显著。
  • 总体抑郁症状严重度关联18个显著适配体(18种独特蛋白质)。
  • 非典型症状关联58个显著适配体(57种独特蛋白质)。
  • 忧郁型症状无个体蛋白质达到FDR显著性,但基因集富集分析识别出线粒体应激反应、蛋白质翻译、补体信号和神经系统发育等通路水平富集。
  • 非典型症状富集于细胞外基质组织、胶原形成、补体级联信号、胰岛素样生长因子转运和染色质调控过程。

临床怎么用

  • 提示临床可考虑采用维度框架评估抑郁症状,尤其关注非典型症状的生物学特征。
  • 外周蛋白质组标志物可能有助于细化抑郁症的生物学分层和生物标志物指导的临床分型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Major depressive disorder (MDD) is biologically heterogeneous and encompasses diverse symptom presentations. The authors used large-scale plasma proteomics to examine proteomic associations with categorical MDD status, continuous depression symptom severity, and DSM-IV-defined melancholic and atypical symptom dimensions. METHODS: Using the SomaScan platform, the authors conducted plasma proteomic profiling of 7,289 analytes in 1,881 participants from the Netherlands Study of Depression and Anxiety, including individuals with current MDD (N=469), individuals with remitted MDD (N=918), and healthy control subjects (N=494). They evaluated associations with diagnostic status, symptom severity, and melancholic and atypical symptom dimensions, followed by pathway enrichment analyses. RESULTS: Eight aptamers, representing seven unique proteins, differed significantly between the current MDD and healthy control groups after false discovery rate (FDR) correction. Overall depression symptom severity was associated with 18 significant aptamers corresponding to 18 unique proteins, whereas atypical symptoms were associated with 58 significant aptamers corresponding to 57 unique proteins. In contrast, no individual proteins reached FDR significance for melancholic symptoms. Pathway analyses showed enrichment for extracellular matrix organization, collagen formation, complement cascade signaling, platelet activation, and hemostasis in relation to overall depression symptom severity. Gene set enrichment analysis of proteins ranked by association with melancholic symptoms identified pathway-level enrichment despite the absence of FDR-significant individual proteins, including mitochondrial stress response, protein translation, complement signaling, and nervous system development. Atypical symptoms showed enrichment of extracellular matrix organization, collagen formation, complement cascade signaling, insulin-like growth factor transport, and chromatin regulatory processes. CONCLUSIONS: These findings support biological heterogeneity within MDD and suggest that peripheral proteomic alterations are more strongly represented for specific symptom dimensions than for categorical diagnosis alone. Atypical symptoms showed pathway-level enrichment with significant individual protein associations. A dimensional framework may improve biological stratification of depression and refine biomarker-informed approaches to clinical symptom profiles.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Watson KT, Bot M, Kosti I, et al. Proteomic Signatures in Major Depressive Disorder and Depression Symptom Subtypes. Am J Psychiatry. 2026. PMID: 42811409. doi:10.1176/appi.ajp.20250891

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。